Lanean...
Drugs for improving esophageal mucosa defense: where are we now and where are we going?
In the past, the attention of physiologists and doctors has been mainly focused on the key role of acid in the pathogenesis of gastroesophageal reflux disease (GERD), but increasing evidence that 20-40% of reflux patients respond not at all or only partially to proton pump inhibitors (PPIs) has unde...
Gorde:
| Argitaratua izan da: | Ann Gastroenterol |
|---|---|
| Egile Nagusiak: | , , , , , , , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
Hellenic Society of Gastroenterology
2017
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5670277/ https://ncbi.nlm.nih.gov/pubmed/29118552 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.20524/aog.2017.0187 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|